Skip to main content
NIH funding notice RFA-DA-23-056

Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)

Closed on November 19, 2024.

Posted
August 17, 2022
Close date
November 19, 2024
Activity codes
R01
Institutes taking part
NIDA, NIAID

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by RFA-DA-26-034.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,362,072 in first-year total cost, median $456,132.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 LXF-N (M1)]2
  2. Special Emphasis Panel[ZDA1 LXF-N (M2)]2
  3. ZDA1-LXF-N(M2)R2
  4. ZDA1-LXF-N(M1)R1

Most frequent institutions

  1. JACKSON LABORATORY1
  2. LOVELACE BIOMEDICAL RESEARCH INSTITUTE1
  3. RUTGERS BIOMEDICAL AND HEALTH SCIENCES1
  4. UNIVERSITY OF CHICAGO1
  5. UNIVERSITY OF MARYLAND BALTIMORE1
Competing awards under RFA-DA-23-056 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Combining Experiments, Simulations, and AI to Interrogate the Pharmacology of Fentanyl and Nitazene Derivatives1R56DA064273-01SHEN, JANAUNIVERSITY OF MARYLAND BALTIMORE, MD$428,432ZDA1
2024Serotonin mechanisms in fentanyl-induced respiratory depression1R01DA061320-01LEVITT, ERICA SAWYERUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$459,424ZDA1
2024Investigating the mechanistic consequences of fentanyl-induced hypoxia and cardiorespiratory collapse1R01DA061412-01GARCIA, ALFREDO JSHARP, WILLARD WILLIAMUNIVERSITY OF CHICAGO, IL$453,600ZDA1
2023Mechanism and Countermeasure of Carfentanil-induced Respiratory Disorder and Death1R01DA059063-01XU, FADILOVELACE BIOMEDICAL RESEARCH INSTITUTE, NM$651,000ZDA1
2023Identifying novel molecular targets, signaling pathways and mechanisms underlying fentanyl overdose-induced severe respiratory depression and lethality in rats using TMT phosphoproteomics/proteomics1R56DA059061-01PAN, YING-XIANRUTGERS BIOMEDICAL AND HEALTH SCIENCES, NJ$471,000ZDA1
2023Genetic Variation of Ultra-Potent Synthetic Opioid Sensitivity in Mice1R01DA059060-01BUBIER, JASON AJACKSON LABORATORY, ME$456,132ZDA1
2023Dissecting the central and peripheral mechanisms to fentanyl induced respiratory depression1R56DA059067-01MORON-CONCEPCION, JOSE AWASHINGTON UNIVERSITY, MO$442,484ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-23-056: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience